Studies have revealed that TNBC has many tumor-infiltrating lymphocytes (TILs) and also overexpress programmed cell death-ligand 1 (PD-L1), indicating that immunotherapy could be a promising approach for treatment [196,197]. The gene discussed is CD274; the disease is neoplasm.